½ÃÀ庸°í¼­
»óǰÄÚµå
1629762

¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2025-2030³â)

Modular Laboratory Automation - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Mordor Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È 6.5%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Modular Laboratory Automation-Market-IMG1

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

  • ½ÃÀå È®´ë°¡ °ð °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª´Â ½ÇÇè½Ç ÀÚµ¿È­°¡ °¡Á®´ÙÁÖ´Â ÀÌÁ¡ÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¿ÏÀüÇÑ ¼öµ¿ °³ÀÔ¿¡¼­ ½ÇÇè½Ç ÀÚµ¿È­·ÎÀÇ ÆÐ·¯´ÙÀÓ º¯È­´Â ÀÓ»ó ½ÇÇè½Ç¿¡ ´Ù¾çÇÑ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú, ¾ÈÀüÇÑ ÀÛ¾÷ ȯ°æ, ³ôÀº »ý»ê¼º, »ó´çÇÑ ½Ã°£, °ø°£ ¹× ºñ¿ë Àý°¨Àº ÁÖ¿ä ÀÌÁ¡ Áß ÀϺο¡ ºÒ°úÇÕ´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È­´Â ½Ã·á È®ÀÎ ¹× Æ©ºê ¶óº§¸µ°ú °°Àº ¹Ýº¹ÀûÀÎ ÇÁ·Î¼¼½º¿¡ ½ÇÇè½Ç Àåºñ¸¦ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô ÇØÁÖ°í, ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½ÅüÀû ºÎ´ãÀ» ÁÙÀ̰í Á¦ÇÑÇÔÀ¸·Î½á ½ÇÇè½Ç ºñ¿ë°ú °ø°£À» Àý¾àÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.
  • ½ÅÈï ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ½ÇÇè½Ç ÀÚµ¿È­ Á¦Ç° Á¦Á¶¾÷ü ¹× À¯Åë¾÷ü¿¡ »ó´çÇÑ ¼ºÀå ÀáÀç·ÂÀ» Á¦°øÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÓ»ó Áø´Ü ÇÁ·Î¼¼½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ½ÇÇè½Ç ÀÚµ¿È­ ÀåºñÀÇ ÆÇ¸Å°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä Á¦Ç° Á¦Á¶¾÷üµéÀº ½ÃÀå Á¡À¯À²À» È®´ëÇϱâ À§ÇØ »õ·Î¿î Áö¿ª¿¡¼­ ÆÇ¸Å¸Á°ú »ý»ê´É·ÂÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ½ÇÇè½Ç ÀÚµ¿È­¿¡ ´ëÇÑ ÀáÀçÀû ÀÌÀÍ Ã¢Ãâ °¡´É¼ºÀ» º¸¿©ÁÝ´Ï´Ù.
  • ¸®Äûµå Çڵ鷯¿Í ·Îº¿ ÆÈÀº ¸ðµâÈ­ µÈ ½ÇÇè½Ç ȯ°æ¿¡¼­ È¿À²¼ºÀ» Çâ»ó½ÃŰ¸é¼­ ´Ù¾çÇÑ ÀÛ¾÷À» ¼öÇàÇÏ´Â µ¥ Á¡Â÷ Æí¸®ÇØÁö°í ÀÖ½À´Ï´Ù. ¹Ý´ë·Î ÀÚµ¿È­ µµ±¸´Â ELISA ºÐ¼® ¼öÇà°ú °°Àº ƯÁ¤ ÀÛ¾÷À» ü°èÀûÀ¸·Î ¼öÇàÇÏ´Â ¼ö¿äµµ ó¸®ÇÕ´Ï´Ù.
  • ÃÖ±Ù ¸î ³â µ¿¾È ºÐÀÚÁø´Ü ºÐ¼®Àº Çü±¤ ¸®Æ÷Å͸¦ »ç¿ëÇÏ¿© PCRÀÌ ÁøÇàµÇ´Â µ¿¾È ½Ç½Ã°£À¸·Î DNAÀÇ ÁõÆøÀ» °¨ÁöÇÏ´Â ½Ç½Ã°£ PCR ±â¼ú¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. Ŭ¸®´ÐÀÇ ºÐÀÚÁø´Ü °Ë»çÀÇ 75 % ÀÌ»óÀÌ ½Ç½Ã°£ PCR ¹æ¹ý¿¡ ÇØ´çÇÕ´Ï´Ù. ÀÌ ±â¼úÀº º¹ÀâÇÑ Áúº´ÀÇ ´õ ³ªÀº Áø´Ü°ú °³º°È­µÈ Ä¡·á¸¦ À§ÇÑ ½Å¼ÓÇÑ ºÐ¼®À» Á¦°øÇÔÀ¸·Î½á »õ·Î¿î ºÐÀÚ»ý¹°ÇÐ ½ÃÀåÀ» ÀÏÀ¸Ä×½À´Ï´Ù.
  • ¶ÇÇÑ, ¾Ï Á¶±â ¹ß°ßÀ» À§ÇÑ ½ÇÇè½Ç ÀÚµ¿È­ µµ±¸ÀÇ »ç¿ë°ú ¹Ì»ý¹°ÇÐ ºÐ¾ß¿¡¼­ÀÇ Ã¤Åà Áõ°¡´Â ºÏ¹Ì¿Í À¯·´ÀÇ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖÀ¸¸ç, MLA(ÀÓ»ó °Ë»ç º¸Á¶) µµ±¸´Â Àεµ¿Í Áß±¹°ú °°Àº ½ÅÈï ½ÃÀå¿¡¼­ Áø´ÜÀ» À§ÇØ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ µµ±¸¿¡ ´ëÇÑ ¼ö¿ä´Â ²ÙÁØÈ÷ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ²ÙÁØÈ÷ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • COVID-19ÀÇ ´ëÀ¯ÇàÀº ÀÓ»ó ½ÇÇè½Ç°ú Á¦¾àȸ»ç¿¡ ´õ ¸¹Àº ºÎ´ãÀ» Áָ鼭 µ¿½Ã¿¡ ÀǾàǰ °³¹ß ¹× ¿¬±¸¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ® ÆÇµ¶±â, ÀÚµ¿ ¾×ü Ãë±Þ ¹× ·Îº¿¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ TAT ´ÜÃàÀ» È®º¸ÇÏ´Â °ÍÀÌ ÃÖ¿ì¼± °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí, Àü¿°º´À¸·Î ÀÎÇØ º´¿ø°ú ÀÇ·á ½Ã½ºÅÛÀÇ ¼öÀͰú ¸¶ÁøÀÌ °¨¼ÒÇϰí, ÀÚµ¿È­ ¹× ±â¼ú ÁöÃâÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ÀÇ Àå±âÀûÀÎ ½ÃÀåµµ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀå µ¿Çâ

ÀÚµ¿ ¾×ü 󸮱Ⱑ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷Áö

  • ¾×ü Çڵ鷯´Â ÀϹÝÀûÀ¸·Î »ýÈ­ÇÐ ¹× È­ÇÐ ½ÇÇè½Ç¿¡¼­ »ç¿ëµË´Ï´Ù. ÀÚµ¿ ¾×ü Ãë±Þ ·Îº¿Àº ½ÇÇè½Ç¿¡¼­ ½Ã·á ¹× ±âŸ ¾×ü¸¦ ºÐ¹èÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÚµ¿ ¾×ü Çڵ鷯´Â ½ÇÇà ½Ã°£À» ÃÖ¼ÒÈ­Çϰí Á¤È®µµ¸¦ ±Ø´ëÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ, ¾×ü Çڵ鷯´Â ³ª³ë¸®ÅÍ¿¡ À̸£´Â ´Ù¾çÇÑ ºÎÇǸ¦ ´Ù·ê ¼ö ÀÖ¾î ºÐÁÖ ÀÛ¾÷¿¡¼­ ±× À¯¿ë¼ºÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù.
  • ÁÖ¿ä ±â¾÷µéÀº ÀÚµ¿ ¾×ü 󸮱⠰³¹ßÀÇ º¥Ä¡¸¶Å©¸¦ ¼³Á¤ÇÏ°í »ý»ê¼ºÀ» È¿°úÀûÀ¸·Î Çâ»ó½Ã۱â À§ÇØ ÇÁ¸®¹Ì¾ö Á¦Ç° °³¹ß¿¡ Áö¼ÓÀûÀ¸·Î ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¹Ì·®ÀÇ ¾×ü¸¦ ó¸®ÇÒ ¼ö ÀÖ´Â ¾×ü 󸮱âÀÇ ÁøÈ­´Â ½ÃÀå¿¡¼­ ¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ÀÇ ±Þ¼ÓÇÑ ¹ßÀü¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
  • Robotic Industries Association¿¡ µû¸£¸é, »ý¸í°úÇÐ ºÐ¾ß´Â ÀÚµ¿ ¾×ü Çڵ鷯, ÀÚµ¿ Ç÷¹ÀÌÆ® Çڵ鷯, ·Îº¿ ÆÈ°ú °°Àº »ê¾÷¿ë ·Îº¿¿¡ ´ëÇÑ ¼ö¿ä°¡ ¼¼ ¹øÂ°·Î ³ôÀº ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.
  • Parker¿¡ µû¸£¸é »ý¸í°úÇÐ ·Îº¿ÀÇ Æ®·»µå Áß Çϳª´Â ·Îº¿ ºÐ¼® ÀåºñÀÇ À¯Ã¼ °øÇÐÀÇ ´Ü¼øÈ­¶ó°í ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÀÓ»ó ½ÇÇè½Ç°ú º´¿øÀÌ Áß¿äÇÑ »ùÇÃÀ» ó¸®ÇÒ ¶§ Àåºñ°¡ ´Ù¿îµÇ´Â °ÍÀ» ¿øÄ¡ ¾Ê±â ¶§¹®¿¡ ¹ß»ýÇß½À´Ï´Ù. °ú°Å¿¡´Â ºÐÁÖ ÀåÄ¡ ³¡¿¡ 50°³ÀÇ ¹Ù´Ã°ú ¸¹Àº Æ©ºê¸¦ »ç¿ëÇÏ´ø ·Îº¿ ½Ã½ºÅÛµµ ÃÖ±Ù¿¡´Â Ư¼ö ¹ëºê ¸Å´ÏÆúµå¸¦ »ç¿ëÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¸Å´ÏÆúµå´Â ±âº»ÀûÀ¸·Î ´©Ãâ °¡´É¼ºÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °ý¸ñÇÒ¸¸ÇÑ ¼ºÀå¼¼¸¦ ±â·Ï

  • ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÁÖ·Î Á¦¾à ½ÃÀåÀÇ ±Þ°ÝÇÑ ¼ºÀåÀ¸·Î ÀÎÇØ ½ÇÇè½Ç ÀÚµ¿È­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¦¾à ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â Àå±âÀûÀÎ °æÁ¦ ¹× Àα¸ µ¿Çâ, Ãß°¡ÀûÀÎ ÀÇ·á °³Çõ, Á¤ºÎÀÇ 5°³³â °èȹ¿¡ ¸í½ÃµÈ Á¤Ã¥À¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í¼ºÀå ½ÃÀåÀº ½ÇÇè½Ç ÀÚµ¿È­ ¼Ö·ç¼Ç °ø±Þ¾÷ü¿¡°Ô »õ·Î¿î ±âȸ¸¦ ¿­¾îÁÖ¸ç, ½ÃÀå Á¡À¯À²À» È®´ëÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.
  • ¿¹¸¦ µé¾î, Áß±¹Àº Á¦¾à »ê¾÷¿¡¼­ ÀÇ·á Á¦Ç°, ¼ÒºñÀÚ À§»ý¿¡ À̸£±â±îÁö ¿©ÀüÈ÷ ¼¼°è¿¡¼­ °¡Àå ¸Å·ÂÀûÀÎ ½ÃÀå Áß ÇϳªÀ̸ç, ´ë±Ô¸ð ½ÅÈï ½ÃÀå Áß °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â ½ÃÀå Áß ÇϳªÀÔ´Ï´Ù. ÃÖ±Ù µé¾î ´Ù¼Ò ÁÖÃãÇÑ ¸ð½ÀÀ» º¸À̰í ÀÖÁö¸¸, ¿©ÀüÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­¿¡ ÀÖ¾î Áß¿äÇÑ ½ÃÀåÀÓ¿¡´Â º¯ÇÔÀÌ ¾ø½À´Ï´Ù.
  • ¶ÇÇÑ ÀÌ Áö¿ªÀº ´Ù¸¥ ´ë·ú°ú ´Þ¸® ÀÌÁúÀûÀÎ Àα¸ Áý´ÜÀÌ ¸¹±â ¶§¹®¿¡ ÀǾàǰ ¿¬±¸¸¦ ¼öÇàÇϱ⿡ ÀÌ»óÀûÀÔ´Ï´Ù. ÀÌ Áö¿ªÀº ¼÷·ÃµÈ ³ëµ¿·ÂÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ°í ÀǾàǰ °³¹ß¿¡ ÇÊ¿äÇÑ ºñ¿ëÀÌ ³·±â ¶§¹®¿¡ ÀǾàǰ ¿¬±¸ ¾Æ¿ô¼Ò½Ì¿¡ °¡Àå ¼±È£µÇ´Â Áö¿ªÀÔ´Ï´Ù.
  • ¸¹Àº Á¶Á÷ÀÌ ¸ðµâ½Ä ½ÇÇè½ÇÀ» äÅÃÇÏ¿© Àú·ÅÇÑ ºñ¿ëÀ¸·Î ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­´Â ½ÃÀå¿¡¼­ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Çѱ¹Àº ±â¼ú ¼±Áø±¹ Áß Çϳª°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±¹³» ±â¾÷µéÀÇ ÀÚµ¿È­ µµÀÔ°ú ±â¼ú Çõ½ÅÀÇ Áõ°¡´Â »ê¾÷ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ »ê¾÷ °³¿ä

¸ðµâ½Ä ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº ´ÜÆíÈ­µÇ¾î ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ÀÓ»ó ¹× ÀüÀÓ»ó½ÃÇèÀÇ ¼ö°¡ ±ÞÁõÇÔ¿¡ µû¶ó ½Ã·á ºÐ¼®ÀÇ ½Å¼ÓÈ­°¡ ½Ã±ÞÈ÷ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ±â°è °¡µ¿ Áß´Ü ½Ã°£°ú ÀηÂÀ» ¸ðµÎ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¸¹Àº ¾÷üµéÀÌ ½ÃÀå¿¡ ÁøÀÔÇÏ¿© ½ÃÀåÀÇ ¸Å·Â°ú °æÀï·ÂÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â hermo Fisher Scientific, Danaher Corporation, Becton Dickinson, Siemens Healthcare, Synchron Lab Automation, Honeywell International, Perkinelmer Inc. Perkinelmer Inc. µîÀÌ ÀÖ½À´Ï´Ù.

  • 2021³â 3¿ù - ÆÛŲ¿¤¸Ó´Â Àåºñ, ½Ã¾à ¹× ¼Ò¸ðǰÀ» Æ÷ÇÔÇÑ SARS-CoV-2 RNA °ËÃâ ¹× ½ºÅ©¸®´×À» À§ÇÑ Àüü ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼ÇÀ» ¹ßÇ¥Çß½À´Ï´Ù. ¸ðµâ½Ä ÀÚµ¿ ¿öÅ©½ºÅ×À̼ǰú ½Å·ÚÇÒ ¼ö ÀÖ´Â ±â¾÷¿ë ¼Ò¸ðǰ ¹× ½Ã¾à °ø±ÞÀ» °áÇÕÇÏ¿© ÇÏ·ç ÃÖ´ë 10,000°³ÀÇ °Ëü¸¦ ó¸®ÇÒ ¼ö ÀÖ¾î SARS-CoV-2 °Ë»ç »ý»ê¼ºÀ» ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • 2021³â 3¿ù - Thermo Fisher ScientificÀº Thermo FisherÀÇ Ç¥ÁØÈ­µÈ COVID-19 °Ë»ç Ç÷§ÆûÀ» À§ÇÑ Æ÷°ýÀûÀ̰í ÅëÇÕµÈ ¼ÒÇÁÆ®¿þ¾î ÀÚµ¿È­ Ç÷§ÆûÀ» °³¹ßÇϱâ À§ÇÑ Àü·«Àû ±â¼ú Á¦ÈÞ¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ÅëÇÕÀº °Ë»ç 󸮷®À» Çâ»ó½ÃŰ°í ¼¼°è ÇコÄɾ ´ëÇÑ ³ë·ÂÀ» Áö¿øÇÒ °ÍÀÔ´Ï´Ù.
  • 2021³â 3¿ù - ÀÇ·á ±â¼ú ¼±±¸ÀÚÀÎ º¤Åæ µðŲ½¼ ¾Ø ÄÄÆÛ´Ï(Beckton Dickinson and Company)´Â ¹Ì±¹¿¡¼­ BD Ű¿¡½ºÆ®¶ó(BD Kiestra) ½ÇÇè½Ç ÀÚµ¿È­ ¹è¾ç ¹× À̹Ì¡ ½Ã½ºÅÛ°ú ¿¬°èµÈ ¼Òº¯ ¹è¾ç ¾ÖÇø®ÄÉÀ̼ÇÀ» Ãâ½ÃÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

±âŸ ÇýÅÃ:

  • ¿¢¼¿ Çü½ÄÀÇ ½ÃÀå ¿¹Ãø(ME) ½ÃÆ®
  • 3°³¿ù°£ÀÇ ¾Ö³Î¸®½ºÆ® Áö¿ø

¸ñÂ÷

Á¦1Àå ¼Ò°³

  • Á¶»ç °¡Á¤°ú ½ÃÀå Á¤ÀÇ
  • Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå °³¿ä
  • »ê¾÷ ¹ë·ùüÀÎ ºÐ¼®
  • ¾÷°èÀÇ ¸Å·Â - Porter's Five Forces ºÐ¼®
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °­µµ
  • COVID-19ÀÇ ¾÷°è¿¡ ´ëÇÑ ¿µÇâ Æò°¡

Á¦5Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¹æ´ëÇÑ µ¥ÀÌÅÍÀÇ ³ôÀº ÀçÇö¼º°ú È¿À²ÀûÀÎ °ü¸®ÀÇ Çʿ伺
    • ¼÷·ÃÀÚÀÇ ºÎÁ·À» º¸ÃæÇÏ´Â ½Å·Ú¼º ³ôÀº ÀÚµ¿È­ ¼Ö·ç¼ÇÀÇ Çʿ伺
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Áß¼Ò±Ô¸ð Á¶Á÷ÀÇ µµÀÔ·ü ÀúÇÏ
    • ³ôÀº ÀÚº» ¿ä°Ç

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • Àåºñ ¹× ¼ÒÇÁÆ®¿þ¾îº°
    • ÀÚµ¿ ¸®Äûµå Çڵ鷯
    • ÀÚµ¿ Ç÷¹ÀÌÆ® Çڵ鷯
    • ·Îº¿ ¾Ï
    • ÀÚµ¿ â°í(ASRS)(ASRS)
    • ¼ÒÇÁÆ®¿þ¾î
    • ºÐ¼®±â
  • ¿ëµµº°
    • Drug Discovery
    • À¯ÀüüÇÐ
    • ´Ü¹éÁúüÇÐ
    • ÀÓ»ó Áø´Ü
    • ±âŸ ÀÀ¿ë ºÐ¾ß
  • Áö¿ªº°
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
    • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ½ºÆäÀÎ
      • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¼¼°è ±âŸ Áö¿ª

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Hudson Robotics Inc.
    • Becton Dickinson
    • Synchron Lab Automation
    • Siemens Healthcare
    • Perkinelmer Inc.
    • Honeywell International Inc.
    • Tecan Group Ltd
    • Agilent Technologies

Á¦8Àå ÅõÀÚ ºÐ¼®

Á¦9Àå ½ÃÀå ±âȸ¿Í ÇâÈÄ µ¿Çâ

ksm 25.01.20

The Modular Laboratory Automation Market is expected to register a CAGR of 6.5% during the forecast period.

Modular Laboratory Automation - Market - IMG1

Key Highlights

  • One of the primary reasons expected to promote market expansion shortly is the rise in benefits given by lab automation. A paradigm change from total manual intervention to lab automation has various advantages for clinical laboratories. Reliable outcomes, safe working conditions, higher productivity, and significant time, space, and cost savings are just a few of the primary benefits. Lab automation makes it easier to utilize laboratory equipment for repetitive processes like sample verification and tube labeling and lowering and limiting the physical strain caused by manual chores, which saves money and space in the lab.
  • Emerging markets are likely to provide considerable growth possibilities for lab automation product manufacturers and distributors during the projected period. Increasing demand for clinical diagnostic processes, resulting in increasing lab automation equipment sales. Major product manufacturers are expanding their distribution networks and production capabilities in new areas to increase their market share. This presents a profitable potential for laboratory automation.
  • Liquid handlers and robotic arms are gradually becoming handy for performing different tasks with increased efficiency in modular laboratory environments. Conversely, the automation tools also handle the demand for the systematic execution of specific tasks, like running ELISA assays.
  • In recent years, molecular diagnostic assays have relied significantly on real-time PCR technology, which detects the amplification of DNA in real-time, while PCR is in progress using a fluorescent reporter. More than 75% of clinic molecular diagnostic tests are amenable to real-time PCR procedures. This technology has provoked a new molecular biology market by offering rapid assays for better diagnosis and personalized treatment of complex diseases.
  • Further, the use of laboratory automation tools in early cancer detection and increased adoption in microbiology have been the major contributors to the market growth in North America and Europe. MLA (Medical Laboratory Assistants) tools are widely employed for diagnosis in emerging markets like India and China, and the demand for these tools is expected to rise steadily.
  • The COVID-19 pandemic has accelerated medicine development and research while putting additional strain on clinical laboratories and pharmaceutical companies. As a consequence of the increased interest in microplate readers, automated liquid handling, and robots, ensuring a shorter TAT has become a priority. On the other hand, the epidemic has resulted in lower revenues and margins for hospitals and health systems, as well as lower expenditures on automation and technology. As a result, the long-term market for modular laboratory automation is impacted.

Modular Laboratory Automation Market Trends

Automated Liquid Handlers Account for the Largest Market Share

  • Liquid handlers are usually employed in biochemical and chemical laboratories. Automated liquid handling robots help in dispensing samples and other liquids in laboratories. Automated liquid handlers minimize run times and maximize accuracy. Moreover, liquid handlers are capable of operating across a wide range of volumes, extending into nanolitres, thus proving their usefulness in dispensing operations.
  • Leading companies have set the benchmark for the development of automated liquid handlers and are constantly investing in developing premium products to increase productivity effectively. The evolution of the liquid handlers, capable of handling minute volumes of liquids, has contributed to the rapid development of modular lab automation systems in the market.
  • According to the Robotic Industries Association, the life science sector has the third-highest growth in industrial robots, in terms of automated liquid handlers, automated plate handlers, robotic arms, and others, to meet the demand.
  • According to Parker, one of the trends in life science robotics is fluidics getting simpler in robotic analyzers. This trend arose because clinical laboratories and hospitals cannot afford an instrument to go down when critical samples are involved. Certain robotic systems that used to have 50 needles on the end of a dispensing unit and lots of tubing increasingly use special valve manifolds that eliminate the need for tubing and result in less chance for failure. The manifolds basically minimize the chance of leakage.

Asia Pacific to Witness Significant Growth Rate

  • The Asia-Pacific region is anticipated to witness increased demand for lab automation solutions, primarily owing to the rapid growth in the pharmaceuticals market in this region. The growth can be attributed to the increased investment in pharmaceutical research and development in Asia-Pacific.
  • In the Asia-Pacific region, the prolongation of economic and demographic trends, further healthcare reforms, and the policies articulated in the government's five-year plan are expected to propel the growth of the market. The high-growth market opens new opportunities for the vendors of lab automation solutions to expand their footprint.
  • For instance, China, from the pharmaceuticals industry to medical products to consumer health, remains one of the world's most attractive markets and by far the fastest-growing of all the large emerging markets. Though there has been some decline in recent times, it remains a significant market for modular lab automation in the Asia-Pacific region.
  • Furthermore, the region is ideal for conducting pharmaceutical research owing to the presence of a large pool of heterogeneous population groups, unlike other continents. This region is preferred the most to outsource pharmaceutical research, owing to the availability of skilled labor and lower cost required in the development of drugs.
  • Many organizations are adopting modular laboratories, offering low-cost and reliable solutions. Modular laboratory automation is experiencing a growing demand in the market. South Korea is expected to become one of the technologically advanced nations. The increasing adoption of automation and innovations in technology by local companies is expected to boost the growth of the industry.

Modular Laboratory Automation Industry Overview

The modular laboratory automation market is fragmented. The rapid growth in the number of clinical and pre-clinical studies across the world has created a faster imperative in sample analysis. It reduces both machine downtime and manpower. With growing demand, companies are entering the market, making it attractive as well as competitive. Some of the key players in the market are Thermo Fisher Scientific, Danaher Corporation, Becton Dickinson, Siemens Healthcare, Synchron Lab Automation, Honeywell International Inc., Perkinelmer Inc., among others.

  • March 2021 - PerkinElmer launched entire workflow solutions for the detection and screening of SARS-CoV-2 RNA, including instruments, reagents, and consumables. The modular automated workstations, combined with a reliable supply of corporate consumables and reagents, can optimize the productivity of SARS-CoV-2 testing by processing up to 10,000 samples per day.
  • March 2021 - Thermo Fisher Scientific announced a strategic technology collaboration to develop a comprehensive and integrated software automation platform for Thermo Fisher's standardized COVID-19 Testing Platform. Increased testing throughput and assistance for global healthcare efforts will emerge from the integration.
  • March 2021 - Becton, Dickinson, and Company, a pioneer in medical technology, has announced the launch of a Urine Culture Application in conjunction with the BD Kiestra lab automation incubation as well as an imaging system in the United States, which has the potential to revolutionize the way microbiology labs approach urine culture analysis.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definitions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of COVID-19 Impact on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Need for Higher Reproducibility and Effective Management of Vast Amounts of Data
    • 5.1.2 Need for Reliable Automation Solution to Substitute the Unavailability of Skilled Personnel
  • 5.2 Market Restraints
    • 5.2.1 Slower Adoption Rates in Small- and Medium-sized Organizations
    • 5.2.2 High Capital Requirements

6 MARKET SEGMENTATION

  • 6.1 By Equipment and Software
    • 6.1.1 Automated Liquid Handlers
    • 6.1.2 Automated Plate Handlers
    • 6.1.3 Robotic Arms
    • 6.1.4 Automated Storage and Retrieval Systems (ASRS)
    • 6.1.5 Software
    • 6.1.6 Analyzers
  • 6.2 By Field of Application
    • 6.2.1 Drug Discovery
    • 6.2.2 Genomics
    • 6.2.3 Proteomics
    • 6.2.4 Clinical Diagnostics
    • 6.2.5 Other Fields of Application
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 Germany
      • 6.3.2.3 Spain
      • 6.3.2.4 Rest of Europe
    • 6.3.3 Asia Pacific
      • 6.3.3.1 China
      • 6.3.3.2 Japan
      • 6.3.3.3 South Korea
      • 6.3.3.4 Rest of Asia Pacific
    • 6.3.4 Rest of the World

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Thermo Fisher Scientific
    • 7.1.2 Danaher Corporation
    • 7.1.3 Hudson Robotics Inc.
    • 7.1.4 Becton Dickinson
    • 7.1.5 Synchron Lab Automation
    • 7.1.6 Siemens Healthcare
    • 7.1.7 Perkinelmer Inc.
    • 7.1.8 Honeywell International Inc.
    • 7.1.9 Tecan Group Ltd
    • 7.1.10 Agilent Technologies

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦